Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash

$141.39 +1.73% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Teleflex Incorporated (TFX) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $5.99B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERSELL / AVOID • D
025507510048
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D
Cash (6)Whales (17)SEC (9)Macro (11)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
$159 Bull$135 Base$105 Bear
📬 FREE TFX RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TFX)Realized 20D OHLCV Swing Band: ±5.7%
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash

Teleflex Incorporated (TFX) advanced +1.73% to $141.39, trading at 92% of its 52-week range ($100.18 – $145). Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 92% of its 52-week range ($100.18 – $145) with RSI-14 at 70.2 (OVERBOUGHT (>70)).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±5.7% around $141.39 (no active unusual options sweep snapshot on file).
  • ▸Primary SEC / Cross-Feed Trigger: TFX Exhibits 1.31x True Net Liquidity Elasticity as Fed-TGA-RRP Prints $5,746B
Live TFX Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TFX)

  • ✓Walkthrough of TFX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
TFX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +17.93%📐 HORIZONTAL RANGE
2026-11-01O $139.0H $141.4L $139.0C $141.4VOL 838.0K
RES: $153.6SUP: $113.5SMA50: $131.4SMA200: $125.3
$146.9$139.1$131.4$123.6$115.9RES $153.6SUP $113.5$141.42026-05-042026-06-172026-08-042026-09-172026-11-01
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TFX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
20.6%/yr Implied 5Y Growth

vs. +17.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TFX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TFX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for TFX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TFX)

Health Care Rank #156 of 188 ⚔️ MMSI vs TFX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (TFX vs. MMSI, HAE, MMED, HTFL)

Industry: Medical/Dental Instruments (21 Tracked Issuers)

Across 188 tracked Health Care securities in the Roarable RQD universe, Teleflex Incorporated (TFX) ranks #156 by composite RQD confidence (48/100, grade D) and #146 by equity capitalization ($5.99B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. MMSI currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with TFX at 48/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
TFX ACTIVE
Teleflex Incorporated
D 48/100 — 56.2% 1.8% +1.73% $5.99B Benchmark Subject
MMSI
Merit Medical Systems Inc.
B 75/100 43.4x 48.7% 7.8% +1.28% $5.58B /mmsi-vs-tfx →
HAE
Haemonetics Corporation
B 74/100 — 59.0% 8.4% +1.24% $5.45B /hae-vs-tfx →
MMED
MiniMed Group Inc.
D 46/100 — 54.2% -3.9% +0.21% $5.42B /mmed-vs-tfx →
HTFL
Heartflow Inc.
D+ 53/100 — 76.8% -12.0% +2.42% $5.26B /htfl-vs-tfx →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000096943

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Teleflex Incorporated (TFX) reported GAAP revenue of $1.99B (+17.2% vs. FY2024 revenue of $1.70B , and +16.4% cumulative change since FY2023) , GAAP net income of -$905.6M, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, TFX closed FY2025 with $6.95B in total assets against $2.54B in total debt (Altman Z-Score: 2.12, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.99B -$905.6M — — $6.95B $2.54B
FY2024 (FY) 2024-12-31 $1.70B $70.2M — — $7.10B $1.56B
FY2023 (FY) 2023-12-31 $1.71B $357.6M — — $3.30B $771.0M

3. TFX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TFX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Teleflex Incorporated (NYSE: TFX) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $141.39 (+1.73% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Active quantitative signal LIQUIDITY_TAILWIND (BULLISH, conviction undefined/100) notes: undefined.

How does TFX compare to MMSI and HAE in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), TFX carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 56.2%, and ROIC of 1.8%. By comparison, MMSI (Merit Medical Systems Inc.) holds a B grade (75/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.58B) and HAE (Haemonetics Corporation) posts a B grade (74/100 RQD, P/E N/A, ROIC 8.4%, cap $5.45B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TFX?

Per TFX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000096943), Teleflex Incorporated generated $1.99B in revenue (+17.2% YoY), -$905.6M in net income, and $0 in free cash flow against $6.95B in total assets and $2.54B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TFX trading relative to its 50-day, 200-day, and 52-week technical levels?

TFX last traded at $141.39 (+1.73% on volume of 838,012 shares), positioning the stock +7.61% above its 50-day simple moving average ($131.39) and +12.81% above its 200-day simple moving average ($125.34). Across its 52-week range of $100.18 to $145.00, TFX sits at the 91.9% percentile with a 14-day RSI of 70.2 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.7% ($133.33 to $149.45).

TFX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Why is TFX stock moving today?

Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.